Note: Ingredients listed on restricted chemical lists
EC/CAS
247-852-1/26628-22-8
Name of the chemical
Sodium Azide
Concentration
0-0.1
General Information
Revision date
2004-09-28
Product name
Human Va2 FITC-Labeled MAb, Clone F1
CAS No.
26628-22-8
1.2.1 Relevant identified uses
Refer to the instruction booklet for proper and intended use. Otherwise, contact supplier for specific applications
supplier name
In USA
Manufacturer Name
Pierce Biotechnology
Emergency telephone
800.424.9300, 202.483.7616
Icons in SDS
Company Information
company name
Pierce Biotechnology
Section 2
SECTION 2: Hazards identification
United States Review the most current and approved institutional guideline, protocol, standard operating procedure(s) and MSDS(s) for the proper handling of institutional materials/equipment associated with the use of this product. Emergency Overview No specific hazard. Not applicable. Target organs Contains material which does not cause damage to the following organs: central nervous system (CNS). Routes of Entry Not available.
Potential Acute Health Effects
Eyes Skin Inhalation Ingestion No known significant effects or critical hazards. Potential chronic health effects Carcinogenic Effects Data CARCINOGENIC EFFECTS: Classified None. by NIOSH [Sodium Azide]. Classified A4 (Not classifiable for human or animal.) by ACGIH [Sodium Azide]. MUTAGENIC EFFECTS: Not available.
Teratogenic Effects
Not available
Medical Conditions Generally Aggravated by Exposure
Repeated or prolonged exposure is not known to aggravate medical condition. by Overexposure: Overexposure /Signs/Symptoms Not available. F1 Europe Classification Xn; R22
Other physicochemical hazards
Not applicable
Health hazards
Harmful if swallowed
Environmental hazards
Not applicable See Toxicological Information (section 11)
